Fredun Pharmaceuticals
FREDUN · Pharma > Pharmaceuticals & Drugs Listing date: March 28, 2016

Stock Price vs Company Growth
1d
1.4%
1w
4.4%
1m
6.5%
3m
3.4%
6m
0.9%
1y
23.7%
5y
31.9%
all
57.1%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec16Sep18Jun20Dec21Jun23Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

712 1.4%
635
790
Company Overview

Sales
407 Cr
Growth: 25.2%
Profit after Tax
18.8 Cr
Growth: 6.3%
Micro Cap
336 Cr
P/E: 17.6x
Industry P/E: 31.8x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 407
Growth 25.2%
EBITDA 12.0%
P/S 0.8x
Dividend 0.1%
P/E 17.6x
Book Value ₹ 286
PEG Ratio 0.7x
ROE 14.7%
P/B 2.5x
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Jun22Sep22Dec22Jun23Dec23Mar24Jun24Sep24
Promoters
Created with Highcharts 8.2.2Jun22Sep22Dec22Jun23Dec23Mar24Jun24Sep24
Others
Created with Highcharts 8.2.2Jun22Sep22Dec22Jun23Dec23Mar24Jun24Sep24
Increase    Decrease    No change
Company Profile Detailed

:The company is engaged in manufacturing of pharmaceutical products.
Investors (2)
Followers (1)